TGTX logo

TGTX
TG Therapeutics Inc

21,479
Mkt Cap
$5.64B
Volume
2.61M
52W High
$46.48
52W Low
$25.28
PE Ratio
12.72
TGTX Fundamentals
Price
$35.33
Prev Close
$34.30
Open
$35.04
50D MA
$30.77
Beta
0.95
Avg. Volume
2.21M
EPS (Annual)
$2.77
P/B
8.47
Rev/Employee
$1.54M
$4,923.45
Loading...
Loading...
News
all
press releases
TGTX Completes Enrollment in Phase III Study on Subcutaneous Briumvi
TG Therapeutics completes enrollment in a phase III study of subcutaneous Briumvi for treating RMS in adults, with data expected by late 2026 or early 2027.
Zacks·3d ago
News Placeholder
More News
News Placeholder
TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Get Free Report) have earned an average recommendation of "Moderate Buy" from the six research firms that are presently covering the stock...
MarketBeat·14d ago
News Placeholder
Ocugen (OCGN) Up 2.9% Since Last Earnings Report: Can It Continue?
Ocugen (OCGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·16d ago
News Placeholder
TG Therapeutics, Inc. $TGTX Shares Bought by JPMorgan Chase & Co.
JPMorgan Chase & Co. raised its holdings in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 56.1% in the third quarter, according to the company in its most recent disclosure with the SEC. The...
MarketBeat·20d ago
News Placeholder
Nordea Investment Management AB Buys Shares of 79,696 TG Therapeutics, Inc. $TGTX
Nordea Investment Management AB purchased a new position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 79,696 shares of the bi...
MarketBeat·21d ago
News Placeholder
TG Therapeutics, Inc. $TGTX Shares Purchased by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. increased its position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 1,278.8% during the fourth quarter, according to its most recent filing with...
MarketBeat·21d ago
News Placeholder
1,922,410 Shares in TG Therapeutics, Inc. $TGTX Acquired by Congress Asset Management Co.
Congress Asset Management Co. purchased a new position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) during the fourth quarter, according to the company in its most recent disclosure...
MarketBeat·26d ago
News Placeholder
TG Therapeutics Procures Additional $500 Mln Funding From Blue Owl Capital
(RTTNews) - TG Therapeutics, Inc. (TGTX), a commercial stage biopharmaceutical company, Thursday announced that it has obtained a new five-year, $750 million senior secured credit facility with funds...
Nasdaq News: Markets·1mo ago
News Placeholder
Penn Capital Management Company LLC Grows Stock Position in TG Therapeutics, Inc. $TGTX
Penn Capital Management Company LLC boosted its holdings in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 17.6% during the third quarter, according to the company in its most recent filing...
MarketBeat·1mo ago
News Placeholder
TG Therapeutics (NASDAQ:TGTX) Shares Up 7.9% - Here's What Happened
TG Therapeutics (NASDAQ:TGTX) Trading 7.9% Higher - Time to Buy...
MarketBeat·1mo ago
<
1
2
...
>

Latest TGTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.